Basire Agnès, Sabatier Florence, Ravet Sophie, Lamy Edouard, Mialhe Agnès, Zabouo Gwladys, Paul Pascale, Gurewich Victor, Sampol José, Dignat-George Françoise
INSERM U608, Laboratoire d'Hématologie et d'Immunologie, UFR de Pharmacie, Université de la Méditerranée, Marseille Cedex 5, France.
Thromb Haemost. 2006 Apr;95(4):678-88.
Endothelial progenitor cells (EPC) display a unique ability to repair vascular injury and promote neovascularization although the underlying molecular mechanisms remain poorly understood. Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) play a critical role in cell migration and angiogenesis by facilitating proteolysis of extracellular matrix. The aim of the present study was to characterize the uPA/uPAR-dependent proteolytic potential of EPC outgrown from human umbilical cord blood and to analyze its contribution to their angiogenic properties in vitro. Cells derived from EPC (EPDC), presenting typical features of late outgrowth endothelial cells, were compared to mature endothelial cells, represented by human umbilical vein endothelial cells (HUVEC). Using quantitative flow cytometry, enzyme-linked immunosorbent assays and zymography, we demonstrated that EPDC displayed higher levels of uPA and uPAR. In conditioned culture media, uPA-dependent proteolytic activity was also found to be significantly increased in EPDC. This activity was paralleled by a higher secretion of pro-metalloproteinase-2 (pro-MMP-2). Inhibition of EPDC-associated uPA by monoclonal antibodies that block either uPA activity or receptor binding, significantly reduced proliferation, migration and capillary like tube formation. Moreover, tumor necrosis factor-alpha and vascular endothelial growth factor, known to be locally secreted in ischemic areas, further increased the proteolytic potential of EPDC by up-regulating uPA and uPAR expression respectively. The EPDC response to these factors was found to be more pronounced than that of HUVEC. In conclusion, these findings indicated that EPDC are characterized by high intrinsic uPA/uPAR-dependent proteolytic potential that could contribute to their invasive and angiogenic behaviour.
内皮祖细胞(EPC)具有修复血管损伤和促进新生血管形成的独特能力,尽管其潜在的分子机制仍知之甚少。尿激酶型纤溶酶原激活剂(uPA)及其受体(uPAR)通过促进细胞外基质的蛋白水解在细胞迁移和血管生成中起关键作用。本研究的目的是表征从人脐带血中生长出的EPC的uPA/uPAR依赖性蛋白水解潜力,并分析其在体外对血管生成特性的贡献。将呈现晚期生长内皮细胞典型特征的EPC来源的细胞(EPDC)与以人脐静脉内皮细胞(HUVEC)为代表的成熟内皮细胞进行比较。使用定量流式细胞术、酶联免疫吸附测定和酶谱分析,我们证明EPDC显示出更高水平的uPA和uPAR。在条件培养基中,还发现EPDC中uPA依赖性蛋白水解活性显著增加。这种活性与前基质金属蛋白酶-2(pro-MMP-2)的更高分泌平行。通过阻断uPA活性或受体结合的单克隆抗体抑制EPDC相关的uPA,显著降低了增殖、迁移和毛细血管样管形成。此外,已知在缺血区域局部分泌的肿瘤坏死因子-α和血管内皮生长因子分别通过上调uPA和uPAR表达进一步增加了EPDC的蛋白水解潜力。发现EPDC对这些因子的反应比HUVEC更明显。总之,这些发现表明EPDC的特征是具有高内在的uPA/uPAR依赖性蛋白水解潜力,这可能有助于其侵袭和血管生成行为。